
Supreme Court takes suo motu cognisance of life-saving medicine pricing
The story in brief
The Supreme Court took suo motu cognisance of the high cost of patented life-saving medicines after the petitioner in a Kerala High Court case passed away. The case, filed in 2022, sought a compulsory licence for Ribociclib, a cancer drug, but remains pending despite 57 adjournments. The Union government has only granted one such licence since 2005, raising concerns over access to affordable medicines.